Transcriptional Regulation by P53

Cited by (575)

Items 101–200 of 575

1. LncRNAs in DNA damage response and repair in cancer cells
   Min Su, Heran Wang, Wenxiang Wang, Ying Wang, Linda Ouyang, Pan Chen, Longzheng Xia, Deliang Cao, Qianjin Liao · 2018 · Acta Biochimica et Biophysica Sinica
2. p53 regulates mitochondrial dynamics by inhibiting Drp1 translocation into mitochondria during cellular senescence
   Young Yeon Kim, Jee‐Hyun Um, Jeong-Hyun Yoon, Da‐Ye Lee, Yoon Jung Lee, Dong Hyun Kim, Joo‐In Park, Jeanho Yun · 2019 · The FASEB Journal
3. Cockayne syndrome group B (CSB) protein: At the crossroads of transcriptional networks
   Renier Vélez-Cruz, Jean‐Marc Egly · 2013 · Mechanisms of Ageing and Development
4. Structural studies of p53 inactivation by DNA-contact mutations and its rescue by suppressor mutations via alternative protein-DNA interactions
   A. Eldar, H. Rozenberg, Yael Diskin‐Posner, Remo Rohs, Zippora Shakked · 2013 · Nucleic Acids Research
5. USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2
   Z Li, Qiongyu Hao, Jianyuan Luo, J Xiong, Sufang Zhang, Weiyi Wang, Liping Bai, W Wang, Mei‐ling Chen, Wei Wang et al. · 2015 · Oncogene
6. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma
   Beilei Zhang, Xinan Wang, Jiacong Deng, Haifeng Zheng, Wei Liu, Si Chen, Jie Tian, Fu Wang · 2019 · Cancer Letters
7. Beyond effector caspase inhibition
   Alexander H. Stegh, Ronald Anthony DePinho · 2011 · Cell Cycle
8. Emerging Roles of p53 Related lncRNAs in Cancer Progression: A Systematic Review
   Tian Lin, Pingfu Hou, Sen Meng, Fang Chen, Tao Jiang, Min-Le Li, Meilin Shi, Jin-Jin Liu, Junnian Zheng, Jin Bai · 2019 · International Journal of Biological Sciences
9. Nuclear translocation of annexin 1 following oxygen-glucose deprivation–reperfusion induces apoptosis by regulating Bid expression via p53 binding
   Xing Li, Yin Zhao, Qian Xia, Lu Zheng, Lu Liu, Baoming Zhao, Jing Shi · 2016 · Cell Death and Disease
10. The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl
    Nina Bacher Reuven, Julia Adler, V Meltser, Y Shaul · 2013 · Cell Death and Differentiation
11. Not all p53 gain-of-function mutants are created equal
    Stephano S. Mello, Laura Donatella Attardi · 2013 · Cell Death and Differentiation
12. Genetics and Biology of Pancreatic Ductal Adenocarcinoma
    Richard Francis Dunne, Aram F. Hezel · 2015 · Hematology/Oncology Clinics of North America
13. Low Levels of p53 Protein and Chromatin Silencing of p53 Target Genes Repress Apoptosis in Drosophila Endocycling Cells
    Bingqing Zhang, Sonam Mehrotra, Wei Lun Ng, Brian R. Calvi · 2014 · PLoS Genetics
14. In vitro and in vivo testing methods of epigenomic endpoints for evaluating endocrine disruptors
    John M. Greally · 2013 · ALTEX
15. Novel RNA-binding activity of MYF5 enhancesCcnd1/Cyclin D1mRNA translation during myogenesis
    Amaresh Chandra Panda, Kotb Abdelmohsen, Jennifer L. Martindale, Clara Di Germanio, Xiaoling Yang, Ioannis Grammatikakis, Ji Heon Noh, Yongqing Zhang, Elin Lehrmann, Dawood Babu Dudekula et al. · 2016 · Nucleic Acids Research
16. p53’s Extended Reach: The Mutant p53 Secretome
    Evangelos Pavlakis, Thorsten Stiewe · 2020 · Biomolecules
17. A Phase I First-in-Human Pharmacokinetic and Pharmacodynamic Study of Serdemetan in Patients with Advanced Solid Tumors
    Tabernero, Josep, Dirix, Luc, Schöffski, Patrick, Cervantes, Andrés, Lopez-Martin, Jose Antonio, Capdevila, Jaume, van Beijsterveldt, Ludy, Platero, Suso, Hall, Brett, Yuan, Zhilong et al. · 2011 · Clinical Cancer Research
18. Salusin-β mediates tubular cell apoptosis in acute kidney injury: Involvement of the PKC/ROS signaling pathway
    Qing-Bo Lu, Qiong Du, Huiping Wang, Zihan Tang, Yuan-Ben Wang, Hai‐Jian Sun · 2019 · Redox Biology
19. Electrical Stimulation Enhances Epidermal Proliferation in Human Cutaneous Wounds by Modulating p53–SIVA1 Interaction
    Anil Sebastian, Syed A. Iqbal, James Colthurst, Susan W. Volk, Ardeshir Bayat · 2014 · Journal of Investigative Dermatology
20. Haploinsufficient tumor suppressor genes.
    Kazushi Inoue, Elizabeth A. Fry · 2017 · PubMed
21. Mutant p53 is a transcriptional co-factor that binds to G-rich regulatory regions of active genes and generates transcriptional plasticity
    Timo Quante, Benjamin Otto, Marie Brázdová, Iva Kejnovská, Wolfgang Deppert, Genrich V. Tolstonog · 2012 · Cell Cycle
22. CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress
    Fekry, Baharan, Jeffries, Kristen A., Esmaeilniakooshkghazi, Amin, Ogretmen, Besim, Krupenko, Sergey A., Krupenko, Natalia I. · 2016 · Journal of Biological Chemistry
23. Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis
    Mina Homayoonfal, Zatollah Asemi, Bahman Yousefi · 2022 · Cellular & Molecular Biology Letters
24. The role of the MDM2/p53 axis in antitumor immune responses
    Tilman Brummer, Robert Zeiser · 2023 · Blood
25. Detailed Review Paper on the State of the Science on Novel In Vitro and In Vivo Screening and Testing Methods and Endpoints for Evaluating Endocrine Disruptors
    OECD · 2012 · OECD series on testing and assessment
26. Coordination between cell proliferation and apoptosis after DNA damage in Drosophila
    Mireya Ruiz-Losada, Raul González, Ana Peropadre, Alejandro Gil‐Gálvez, Juan J. Tena, Antonio Baonza, Carlos Estella · 2021 · Cell Death and Differentiation
27. Phenotype Specific Analyses Reveal Distinct Regulatory Mechanism for Chronically Activated p53
    Kristina Kirschner, Shamith Samarajiwa, Jonathan Cairns, Suraj Menon, Pedro Antonio Pérez-Mancera, Kosuke Tomimatsu, Camino Bermejo‐Rodríguez, Yoko Ito, Tamir Chandra, Masako Narita et al. · 2015 · PLoS Genetics
28. Transcriptional Regulation of thep53Tumor Suppressor Gene in S-Phase of the Cell-Cycle and the Cellular Response to DNA Damage
    David Reisman, Paula Takahashi, Amanda Polson, Kristy Boggs · 2012 · Biochemistry Research International
29. Fiber Light-Coupled Optofluidic Waveguide (FLOW) Immunosensor for Highly Sensitive Detection of p53 Protein
    Lili Liang, Long Jin, Yang Ran, Li‐Peng Sun, Bai‐Ou Guan · 2018 · Analytical Chemistry
30. Cytostatic and Anti-tumor Potential of Ajwa Date Pulp against Human Hepatocellular Carcinoma HepG2 Cells
    Sahabjada Siddiqui, Rumana Ahmad, Mohsin Ali Khan, Shivbrat Upadhyay, Ishrat Husain, Anand Srivastava · 2019 · Scientific Reports
31. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex
    Martin Fischer, Marianne Quaas, Annina Nickel, Kurt Engeland · 2015 · Oncotarget
32. Loss of Slug Compromises DNA Damage Repair and Accelerates Stem Cell Aging in Mammary Epithelium
    Gross, Kayla M., Zhou, Wenhui, Breindel, Jerrica L., Ouyang, Jian, Jin, Dexter X., Sokol, Ethan S., Gupta, Piyush B., Huber, Kathryn, Zou, Lee, Kuperwasser, Charlotte · 2019 · Cell Reports
33. VRK1 phosphorylates and protects NBS1 from ubiquitination and proteasomal degradation in response to DNA damage
    Diana M. Monsalve, Ignacio Campillo‐Marcos, Marcella Salzano, Marta Sanz-García, Lara Cantarero, Pedro A. Lazo · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
34. Selective killing of p53‐deficient cancer cells by SP600125
    Mohamed Jèmaà, Ilio Vitale, Oliver Kepp, Francesco Berardinelli, Lorenzo Galluzzi, Laura Senovilla, Guillermo Mariño, Shoaib Ahmad Malik, Santiago Rello‐Varona, Delphine Lissa et al. · 2012 · EMBO Molecular Medicine
35. Differentiated embryo-chondrocyte expressed gene 1 regulates p53-dependent cell survival versus cell death through macrophage inhibitory cytokine-1
    Yingjuan Qian, Yong-Sam Jung, Xinbin Chen · 2012 · Proceedings of the National Academy of Sciences
36. Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
    Tiffany DeVine, Mu‐Shui Dai · 2013 · Current Pharmaceutical Design
37. AP endonuclease 1 (Apex1) influences brain development linking oxidative stress and DNA repair
    De‐Sheng Pei, Pan‐Pan Jia, Juanjuan Luo, Wei Liu, Phyllis R. Strauss · 2019 · Cell Death and Disease
38. To repress or not to repress: This is the guardian's question
    John L. Rinn, Maite Huarte · 2011 · Trends in Cell Biology
39. USP7 enforces heterochromatinization of p53 target promoters by protecting SUV39H1 from MDM2-mediated degradation.
    Mungamuri, Sathish Kumar, Qiao, Rui F., Yao, Shen, Manfredi, James J., Gu, Wei, Aaronson, Stuart A. · 2016 · Cell Reports
40. Anti-cancer properties of quercetin in osteosarcoma
    Parisa Maleki Dana, Fatemeh Sadoughi, Zatollah Asemi, Bahman Yousefi · 2021 · Cancer Cell International
41. Heat stress: A risk factor for skin carcinogenesis
    Leslie Calapre, Elin Solomonovna Gray, Mel R. Ziman · 2013 · Cancer Letters
42. NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2
    Howard Donninger, Diego Francesco Calvisi, Thibaut Barnoud, Jennifer Clark, Marianne Schmidt, Michele D. Vos, Geoffrey J. Clark · 2015 · The Journal of Cell Biology
43. Mdm2 and MdmX as Regulators of Gene Expression
    Lynn Biderman, James L. Manley, Carol L. Prives · 2012 · Genes & Cancer
44. The many interactions between the innate immune system and the response to radiation
    Serge M. Candéias, Isabelle Testard · 2015 · Cancer Letters
45. Molecular signatures of ovarian diseases: Insights from network medicine perspective
    Medi Kori, Esra Göv, Kazım Yalçın Arğa · 2016 · Systems Biology in Reproductive Medicine
46. Multivalency regulates activity in an intrinsically disordered transcription factor
    Sarah J. Clark, Janette B. Myers, Ashleigh King, Radovan Fiala, Jiří Nováček, Frederick Grant Pearce, Jörg Heierhorst, Steve Reichow, Elisar J. Barbar · 2018 · eLife
47. Molecular docking studies, drug-likeness and in-silico ADMET prediction of some novel β-Amino alcohol grafted 1,4,5-trisubstituted 1,2,3-triazoles derivatives as elevators of p53 protein levels
    Zakari Ya’u Ibrahim, Adamu Uzairu, Gideon Adamu Shallangwa, Stephen Eyije Abechi · 2020 · Scientific African
48. Mule determines the apoptotic response to HDAC inhibitors by targeted ubiquitination and destruction of HDAC2
    Jing Zhang, Shu Kan, Bryant Huang, Zhenyue Hao, Tak W. Mak, Qing Zhong · 2011 · Genes & Development
49. Mutant p53 in cell-cell interactions
    Steven E. Pilley, Tristan A. Rodríguez, Karen H. Vousden · 2021 · Genes & Development
50. Predominant role of DNA polymerase eta and p53-dependent translesion synthesis in the survival of ultraviolet-irradiated human cells
    Lerner, Leticia K., Francisco, Guilherme, Soltys, Daniela T., Rocha, Clarissa R.R., Quinet, Annabel, Vessoni, Alexandre T., Castro, Ligia P., David, Taynah I.P., Bustos, Silvina O., Strauss, Bryan E. et al. · 2017 · Nucleic Acids Research
51. The role of p53 in the alternation of vascular functions
    Gabriel Hoi Huen Chan, Enoch Chan, Carsten Tsun‐Ka Kwok, Gph Leung, Simon Ming‐Yuen Lee, Sai Wang Seto · 2022 · Frontiers in Pharmacology
52. Serine/Threonine Kinase 17A Is a Novel p53 Target Gene and Modulator of Cisplatin Toxicity and Reactive Oxygen Species in Testicular Cancer Cells
    Pingping Mao, Mary P. Hever-Jardine, Lynn Niemaszyk, Jessica M. Haghkerdar, Esty G. Yanco, Damayanti Desai, Maroun J. Beyrouthy, Joanna S. Kerley-Hamilton, Sarah J. Freemantle, Michael J. Spinella · 2011 · Journal of Biological Chemistry
53. CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damage
    Charles Vadnais, Sayeh Davoudi, Mojdeh Afshin, Ryoko Harada, Rachel Dudley, Pier‐Luc Clermont, Elliot A. Drobetsky, Alain Nepveu · 2012 · Nucleic Acids Research
54. Combined HDAC1 and HDAC2 Depletion Promotes Retinal Ganglion Cell Survival After Injury Through Reduction of p53 Target Gene Expression
    Frédéric Lebrun-Julien, Ueli Suter · 2015 · ASN NEURO
55. p53 Requires an Intact C-Terminal Domain for DNA Binding and Transactivation
    Hyun‐Jung Kim, Kyunghwan Kim, Jongkyu Choi, Kyu Heo, Hwa Jin Baek, Robert G. Roeder, Woojin An · 2011 · Journal of Molecular Biology
56. Life or death
    Katharina Schlereth, Joël P. Charles, Anne Catherine Bretz, Thorsten Stiewe · 2010 · Cell Cycle
57. Roles of Atox1 and p53 in the trafficking of copper-64 to tumor cell nuclei: implications for cancer therapy
    Wissam Beaino, Yunjun Guo, Albert J. Chang, Carolyn J. Anderson · 2014 · JBIC Journal of Biological Inorganic Chemistry
58. Long story short: p53 mediates innate immunity
    Jessica J. Miciak, Fred Bunz · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
59. HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress
    Nirmalya Sen, Rajni Kumari, Manika Indrajit Singh, Sanjeev Das · 2013 · Molecular Cell
60. Post-translational regulation of p53 function through 20S proteasome-mediated cleavage
    Hilla Solomon, Bastian Bräuning, Irit Fainer, Gili Ben‐Nissan, Stav Rabani, Naomi Goldfinger, Oren Moscovitz, Zippora Shakked, Varda Rotter, Michal Sharon · 2017 · Cell Death and Differentiation
61. Aberrant expression of ETS1 and ETS2 proteins in cancer
    Elizabeth A. Fry, Kazushi Inoue · 2018 · Cancer Reports and Reviews
62. Starvation Promotes REV1 SUMOylation and p53-Dependent Sensitization of Melanoma and Breast Cancer Cells
    Hong Seok Shim, Min Wei, Sebastian Brandhorst, Valter Daniel Longo · 2015 · Cancer Research
63. p53 Basic C Terminus Regulates p53 Functions through DNA Binding Modulation of Subset of Target Genes
    Pierre-Jacques Hamard, Dana J. Lukin, James J. Manfredi · 2012 · Journal of Biological Chemistry
64. Functional interplay between p53 acetylation and H1.2 phosphorylation in p53-regulated transcription
    Kyunghwan Kim, Kwang Won Jeong, Hyun‐Jung Kim, Jongkyu Choi, Wange Lu, Michael R. Stallcup, Woojin An · 2012 · Oncogene
65. The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System
    Stephen Armstrong, Hong Wu, Benfan Wang, Yasser Abuetabh, Consolato Maria Sergi, Roger P. Leng · 2016 · International Journal of Molecular Sciences
66. p53 and RAD9, the DNA Damage Response, and Regulation of Transcription Networks
    Howard B. Lieberman, Sunil K. Panigrahi, Kevin M. Hopkins, Li Wang, Constantinos G. Broustas · 2017 · Radiation Research
67. p53-Autophagy-Metastasis Link
    Tatiana V. Denisenko, Anastasia D. Pivnyuk, Boris Zhivotovsky · 2018 · Cancers
68. Transcription factors in epithelial ovarian cancer: histotype-specific drivers and novel therapeutic targets
    Robbin A. Nameki, Heidi S. Y. Chang, Jessica Reddy, Rosario I. Corona, Kate Lawrenson · 2020 · Pharmacology & Therapeutics
69. LncRNAs: New Players in Gliomas, With Special Emphasis on the Interaction of lncRNAs With EZH2
    Erbao Bian, Jia Li, Yongsheng Xie, Gang Zong, Jun Li, Bing Zhao · 2014 · Journal of Cellular Physiology
70. Reverting p53 activation after recovery of cellular stress to resume with cell cycle progression
    Pedro A. Lazo · 2017 · Cellular Signalling
71. TRIM35-mediated degradation of nuclear PKM2 destabilizes GATA4/6 and induces P53 in cardiomyocytes to promote heart failure
    Maria Areli Lorenzana Carrillo, Keshav Gopal, Nikole J. Byrne, Saymon Tejay, Bruno Saleme, Subhash K. Das, Yongneng Zhang, Alois Haromy, Farah Eaton, Michelle Mendiola et al. · 2022 · Science Translational Medicine
72. p53 attenuates AKT signaling by modulating membrane phospholipid composition
    Natalia Rueda-Rincón, Katarzyna M. Bloch, Rita Derua, Rajesh Vyas, Amy C. Harms, Thomas Hankemeier, Niamat Ali Khan, Jonas Dehairs, Muralidhararao Bagadi, María Mercedes Binda et al. · 2015 · Oncotarget
73. Myeloid p53 regulates macrophage polarization and venous thrombus resolution by inflammatory vascular remodeling in mice
    Subhradip Mukhopadhyay, Toni Antalis, Khanh P. Nguyen, Mark Houston Hoofnagle, Rajabrata Sarkar · 2017 · Blood
74. An Orc1/Cdc6 ortholog functions as a key regulator in the DNA damage response in Archaea
    Mengmeng Sun, Xu Feng, Zhenzhen Liu, Wenyuan Han, Yun Xiang Liang, Qunxin She · 2018 · Nucleic Acids Research
75. A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer
    Jessica J. Miller, Christian Gaiddon, Tim Storr · 2020 · Chemical Society Reviews
76. Sam68 functions as a transcriptional coactivator of the p53 tumor suppressor
    Naomi Li, Stéphane Richard · 2016 · Nucleic Acids Research
77. The Enigma of miRNA Regulation in Cancer
    Anjan K. Pradhan, Luni Emdad, Swadesh Kumar Das, Devanand Sarkar, Paul B. Fisher · 2017 · Advances in cancer research
78. New Insights into the Role of DNA Shape on Its Recognition by p53 Proteins
    Dmitrij Golovenko, Bastian Bräuning, Pratik Vyas, Tali E. Haran, H. Rozenberg, Zippora Shakked · 2018 · Structure
79. MT1G serves as a tumor suppressor in hepatocellular carcinoma by interacting with p53
    Yingchao Wang, Gaoxiong Wang, Xionghong Tan, Kun Ke, Bixing Zhao, Niangmei Cheng, Yuan Dang, Naishun Liao, Fei Wang, Xiaoyuan Zheng et al. · 2019 · Oncogenesis
80. Targeting key proteins involved in transcriptional regulation for cancer therapy: Current strategies and future prospective
    Haixiang Pei, Weikai Guo, Yangrui Peng, Hai Xiong, Yihua Chen · 2022 · Medicinal Research Reviews
81. Transcriptome Profiling of the Theca Interna in Transition from Small to Large Antral Ovarian Follicles
    Nicholas Hatzirodos, Katja Hummitzsch, Helen F. Irving‐Rodgers, Raymond Joseph Rodgers · 2014 · PLoS ONE
82. Hepatitis C Virus NS2 Protein Inhibits DNA Damage Pathway by Sequestering p53 to the Cytoplasm
    Cíntia Bittar, Shubham Shrivastava, Joydip Bhanja Chowdhury, Paula Rahal, Ratna B. Ray · 2013 · PLoS ONE
83. Profiling Dose-Dependent Activation of p53-Mediated Signaling Pathways by Chemicals with Distinct Mechanisms of DNA Damage
    Rebecca A. Clewell, Bin Sun, Yeyejide A. Adeleye, Paul Lawford Carmichael, Alina Efremenko, Patrick D. McMullen, Salil N. Pendse, O. Joseph Trask, Andy White, Melvin E. Andersen · 2014 · Toxicological Sciences
84. Mutant p53 establishes targetable tumor dependency by promoting unscheduled replication
    Shilpa Singh, Catherine A. Vaughan, Rebecca A. Frum, Steven R. Grossman, Sumitra Deb, Swati Palit Deb · 2017 · Journal of Clinical Investigation
85. Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC
    Yaqun Zhang, Lingfan Xu, Yan Chang, YanJing Li, William Butler, Er Jin, Aifen Wang, Yulei Tao, Xufeng Chen, Chang Yin Liang et al. · 2019 · Prostate Cancer and Prostatic Diseases
86. Flavonoid-rich extracts from okra flowers exert antitumor activity in colorectal cancer through induction of mitochondrial dysfunction-associated apoptosis, senescence and autophagy
    Yuanle Deng, Sha Li, Meng Wang, Xiaotong Chen, Tian Xiang Li, Liqun Wang, Wenyu Yang, Lezhang Chen, Fang He, Wenya Yin · 2020 · Food & Function
87. Is p53 Involved in Tissue‐Specific Insulin Resistance Formation?
    Justyna Strycharz, Józef Drzewoski, Janusz Szemraj, Agnieszka Śliwińska · 2017 · Oxidative Medicine and Cellular Longevity
88. Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders
    Doris Loh, Russel Joseph Reiter · 2021 · Antioxidants
89. Poldip2 Knockout Results in Perinatal Lethality, Reduced Cellular Growth and Increased Autophagy of Mouse Embryonic Fibroblasts
    David Brown, Bernard P Lassegue, Minyoung Lee, Rostam Zafari, James S. Long, Harold Ivan Saavedra, Kathy K. Griendling · 2014 · PLoS ONE
90. DNA damage stress induces the expression of Ribosomal Protein S27a gene in a p53-dependent manner
    Nagisa Nosrati, Neetu Rohit Kapoor, Vijay Kumar · 2015 · Gene
91. p53 regulation upon genotoxic stress: intricacies and complexities
    Rajni Kumari, Saishruti Kohli, Sanjeev Das · 2014 · Molecular & Cellular Oncology
92. NuMA Is Required for the Selective Induction of p53 Target Genes
    Hirokazu Ohata, Makoto Miyazaki, Ryo Otomo, Yuko Matsushima‐Hibiya, Chihiro Otsubo, Takahiro Nagase, Hirofumi Arakawa, Jun Yokota, Hitoshi Nakagama, Yoichi Taya et al. · 2013 · Molecular and Cellular Biology
93. Accumulation of p53 via down-regulation of UBE2D family genes is a critical pathway for cadmium-induced renal toxicity
    Jin-Yong Lee, Maki Tokumoto, Yasuyuki Fujiwara, Tatsuya Hasegawa, Yoshiyuki Seko, Akinori Shimada, Masahiko Satoh · 2016 · Scientific Reports
94. Transcription factors: Time to deliver
    Alexey V. Ulasov, Andrey A. Rosenkranz, Alexander S. Sobolev · 2017 · Journal of Controlled Release
95. Filling gaps in translesion DNA synthesis in human cells
    Annabel Quinet, Letícia Koch Lerner, Davi Jardim Martins, Carlos Frederico Martins Menck · 2018 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
96. Apigenin and Hesperidin Downregulate DNA Repair Genes in MCF-7 Breast Cancer Cells and Augment Doxorubicin Toxicity
    Agnieszka Korga-Plewko, Monika Michalczyk, Grzegorz Adamczuk, Ewelina Humeniuk, Marta Ostrowska-Leśko, Aleksandra Józefczyk, Magdalena Iwan, Marta Wójcik, Jarosław Dudka · 2020 · Molecules
97. DNA damage response signaling: A common link between cancer and cardiovascular diseases
    Sepideh Nikfarjam, Krishna Kumar Singh · 2022 · Cancer Medicine
98. A nanobody modulates the p53 transcriptional program without perturbing its functional architecture
    Jonas Bethuyne, Steven De Gieter, Olivier Zwaenepoel, Abel Garcia‐Pino, Kaat Durinck, Adriaan Verhelle, Gholamreza Hassanzadeh‐Ghassabeh, Frank Speleman, Remy Loris, Jan Gettemans · 2014 · Nucleic Acids Research
99. Association of p53 with Neurodegeneration in Parkinson’s Disease
    Qiang Luo, Wei Sun, Yifan Wang, Ji Li, Da-Wei Li · 2022 · Parkinson s Disease
100. The Role of SIRT1 in Cancer
     Melissa J. Wilking, Nihal Ahmad · 2014 · American Journal Of Pathology